Clinical analysis of 382 immediately breast reconstruction after mastectomy in Beijing City, Tianjin City and Hebei Province from 2012 to 2016
10.3760/cma.j.issn.0529-5815.2020.02.006
- VernacularTitle: 2012—2016年京津冀地区382例乳腺癌术后即刻乳房重建临床分析
- Author:
Chao ZHANG
1
;
Haihui SUN
2
;
Jie LI
1
;
Hongchuan JIANG
1
;
Shan GUAN
3
;
Xiang WANG
4
;
Bing WEN
5
;
Tao OUYANG
6
;
Xiru LI
7
;
Cuizhi GENG
8
;
Jian YIN
9
Author Information
1. Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
2. Department of General Surgery, Beiyuan Street Community Health Service Center, Beijing 101100, China
3. Department of Breast Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
4. Department of Breast Surgery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China
5. Department of Plastic Surgery, Peking University First Hospital, Beijing 100034, China
6. Department of Breast Surgery, Beijing Cancer Hospital, Beijing 100142, China
7. Department of General Surgery, People′s Liberation Army General Hospital, Beijing 100039, China
8. Department of General Surgery, Hebei Cancer Hospital, Shijiazhuang 050011, China
9. Department of Cancer Surgery Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Mammaplasty;
Breast implants
- From:
Chinese Journal of Surgery
2020;58(2):105-109
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize the status of immediate breast reconstruction (IBR) after mastectomy in Beijing City, Tianjin City and Hebei Province.
Methods:A retrospective analysis was made on the data of 382 cases with breast cancer who were treated and followed up successfully with immediate breast reconstruction after mastectomy from January 2012 to December 2016 in Beijing City, Tianjin City and Hebei Province. Clinic data of the followed-up 382 cases (all female, age (38.5±4.2) years (range: 24 to 70 years)), including general information, tumor information, sugery methods, and treatments after surgery were collected. The survival status, metastasis,complications and prognosis were followed up. Cosmetic effcet was evalated by Harris method, and life quality by Functional Assessment of Cancer Therapy-Breast scale (FACT-B). χ2 test was used to compare the difference between year 2012 and year 2013 to 2016. Bonferroni method was used to correct the inspection level, which was 0.05/10=0.005. The trend of IBR rate (ratio of IBR to modified radical mastectomy) from 2013 to 2016 was analyzed by trend χ2 test.
Results:There was 46 cases in stage 0, 152 cases in stage Ⅰ, 165 cases in stage Ⅱ, 19 cases in stage Ⅲ. Twenty-five cases was treated by neoadjuvant chemotherapy, 231 by chemotherapy and 35 by radiotherapy. The proportion of implant reconstruction was 48.7% (186/382), more than expanded of 21.5% (82/382), with latissimus dorsi of 12.0% (46/382), TRAM of 8.9% (34/382), DIEP of 2.1% (8/382), and latissimus plus implant of 6.8% (26/382). According to the Harris standard, the excellent and good rate of the cosmetic effect of the reconstructed breast was 93.7%. The score of FACT-B was 108.20±16.9 (range: 67 to 144) 1 year postoperatively. Compared with 2012, the IBR rate was significant increased, till 2015, the IBR rate was 153/10 000 cases (χ2=47.028, P=0.000).
Conclusions:There is a significant increase on IBR rate in Beijing City, Tianjin City and Hebei province by year. Most of cases received IBR is stage Ⅰ to Ⅱ. Implant reconstruction is the main reconstructive method. Postoperative cosmetic effects and quality of life are both meet patients′ demon.
